Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lijian Pang

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
British Journal of Hospital Medicine (London, England : 2005)|April 23, 2025
A Systematic Review of Mortality Risk Prediction Models for Idiopathic Pulmonary FibrosisYingxu Wu, Pin Li, Mei Wang, et al.
Reviews in Medical Virology|February 27, 2026
Viral Pathogens and Pulmonary Fibrosis: EMT-Driven Mechanisms and Insights From Traditional Chinese MedicineNingzi Zang, Yingxu Wu, Pin Li, et al.
Journal of Ethnopharmacology|December 20, 2023
The mechanism of Shenlong Jianji treatment of idiopathic pulmonary fibrosis inhibits fibroblast-to-myofibroblast transformation via the TGF-β1/smads signaling pathwayJiaxiang Pan, Yue Li, Xize Wu, et al.
Journal of Ethnopharmacology|October 8, 2025
Evidence map analysis of clinical studies on 42 commonly used oral Chinese patent medicines for the treatment of stable chronic obstructive pulmonary diseaseJingze Li, Quan Yuan, Ruizhi Yu, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
British Journal of Hospital Medicine (London, England : 2005)|April 23, 2025
A Systematic Review of Mortality Risk Prediction Models for Idiopathic Pulmonary FibrosisYingxu Wu, Pin Li, Mei Wang, et al.
Reviews in Medical Virology|February 27, 2026
Viral Pathogens and Pulmonary Fibrosis: EMT-Driven Mechanisms and Insights From Traditional Chinese MedicineNingzi Zang, Yingxu Wu, Pin Li, et al.
Journal of Ethnopharmacology|December 20, 2023
The mechanism of Shenlong Jianji treatment of idiopathic pulmonary fibrosis inhibits fibroblast-to-myofibroblast transformation via the TGF-β1/smads signaling pathwayJiaxiang Pan, Yue Li, Xize Wu, et al.
Journal of Ethnopharmacology|October 8, 2025
Evidence map analysis of clinical studies on 42 commonly used oral Chinese patent medicines for the treatment of stable chronic obstructive pulmonary diseaseJingze Li, Quan Yuan, Ruizhi Yu, et al.
Pageof 2